期刊文献+

临床药师对心力衰竭合并低钠血症患者的药学监护 被引量:3

Pharmaceutical Care for Patients with Heart Failure and Hyponatremia by Clinical Pharmacists
原文传递
导出
摘要 目的:探讨临床药师在面对心力衰竭合并低钠血症患者时应如何进行药学监护。方法:临床药师从低钠血症的形成机制、高危诱发因素等方面对低钠血症的用药进行分析和讨论,并实施药学监护。结果:在心力衰竭合并低钠血症患者的药学监护中,临床药师可通过合理使用利尿药,制订个体化限盐方案、补盐措施,监测并纠正低蛋白血症及低钾血症等方式,实现对低钠血症的有效防护及纠正。结论:应深入了解低钠血症的形成机制、危险诱发因素及预防措施,结合患者具体情况,开展个体化的低钠血症药学监护。 OBJECTIVE: To explore the way to provide pharmaceutical care for patients with heart failure complicating with hy- ponatremia by clinical pharmacists. METHODS: The medication of hyponatremia was analyzed and discussed in respect of patho- genesis and risk factors, and the key points of pharmaceutical care were provided. RESULTS: In the clinical pharmaceutical care, rational use of diuretics, appropriate salt intake and the correcting of hypoalbuminemia or low potassium were found effectively on the control of hyponatremia in patients with heart failure. CONCLUSIONS: Individual pharmaceutical care should be provided on the base of the patient' s individual characteristics in addition with deeply learning about the pathogenesis, risk factors and precau- tion of hyponatremia.
出处 《中国药房》 CAS CSCD 2014年第14期1331-1333,共3页 China Pharmacy
关键词 心力衰竭 低钠血症 药学监护 Heart failure Hyponatremia Pharmaceutical care
  • 相关文献

参考文献7

二级参考文献47

  • 1楚翠霞,杨俊敏,魏太星.充血性心力衰竭与电解质紊乱[J].心血管病学进展,1993,14(5):270-273. 被引量:41
  • 2周继红.高钠血症对全身炎症反应综合征患者转归的影响[J].中国医师杂志,2007,9(1):65-66. 被引量:2
  • 3李裕舒.慢性充血性心力衰竭治疗时低钠血症的形成及其对预后的影响[J].临床心血管病杂志,1996,12(6):391-392. 被引量:40
  • 4COHN J N. Overview of the treatment of heart failure[J]. Am J Cardiol, 1997, 80(11A): 2-6.
  • 5董承琅,陈万春.实用心脏病学[M].第3版.上海:上海科学技术出版社,1994:496-560.
  • 6CHATTERJEE K. Neurohormonal activation in congestive heart failure and the role of vasopressin[J]. Am J Cardiol, 2005, 95(9A): 8-13.
  • 7MACFADYEN R J, LEE A F, MORTON J J, et al. How often are angiotensin Ⅱ and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure[J]. Heart, 1999, 82(1): 57-61.
  • 8WEBER K T, VILLARREAL D. Aldosterone and antialdosterone therapy in congestive heart failure[J]. Am J Cardiol, 1993, 71(3): 3-11.
  • 9ACC/AHA Task Force.Guideline for the evaluation andmanagement for heart failure[J].Circulation,1995,92:2764-2784.
  • 10Formlga F,Espel E,Chivite D,et al.Dying from heart failure in hospital:palliative decision making analysis[J].Heart,2002,88:187.

共引文献15

同被引文献24

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部